In this letter, continuous-wave laser gain at 1.06 and 1.3 μm is demonstrated in the neodymium aluminum borate [NdAl3(BO3)4] system. End pumping is achieved by means of a tunable argon-pumped Ti:sapphire and a diode laser. We report on low absorbed pump power at threshold and high pump-to-laser conversion efficiencies (up to 43% and 25% for laser oscillations at 1.06 and 1.3 μm, respectively) in a 0.3 mm long crystal. These good laser properties together with some other spectroscopic parameters described in this work (such as a 100% absorbance, a broad absorption spectrum around 800 nm and high emission cross section at 1.3 μm) make NdAl3(BO3)4 a promising material for diode-pumped microchip lasers.
A comparative study of the optical absorption and luminescence of crystals
of NdAl3(BO3)4 (NAB), Nd:GdAl3(BO3)4 (NGAB)
and Nd:Gd0.2Y0.8Al3(BO3)4 (NGYAB) is
presented. The Judd-Ofelt theory is applied to the fitting of
experimental absorption line strengths to obtain the intensity
parameters Ωt (t = 2,4,6) with root mean square errors of
11.8%, 3.8% and 8.6% for NAB, NGAB and NGYAB respectively. The
intensity parameters are used to calculate the radiative transition
rates, branching ratios and radiative lifetimes of Nd3+ ions
undergoing transitions from 4F3/2 to 4IJ
manifolds. The relevant spectroscopic parameters for laser
applications (quantum efficiency and emission cross section) are
also estimated. The results are compared among the three samples
and other borate crystals. It is concluded that NAB is a laser
crystal with high gain and thus a promising candidate for microchip
laser application, while NGAB (or NGYAB) can be used as an
alternative to the celebrated nonlinear laser crystal NYAB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.